FATE THERAPEUTICS INC Gain (Loss) on Disposition of Assets
FATE THERAPEUTICS INC (FATE) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-12.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2016-03-03
- FATE THERAPEUTICS INC gain (loss) on disposition of assets for the quarter ending 2013-12-31 was $0.00.
- FATE THERAPEUTICS INC gain (loss) on disposition of assets for fiscal 2014 was $0.00.
- FATE THERAPEUTICS INC gain (loss) on disposition of assets for fiscal 2013 was -$18.00K.
- FATE THERAPEUTICS INC gain (loss) on disposition of assets for fiscal 2012 was $0.00.
- FATE THERAPEUTICS INC gain (loss) on disposition of assets for fiscal 2011 was -$117.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 77 month | Gain (Loss) on Disposition of Assets 80 month | Gain (Loss) on Disposition of Assets 83 month |
|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-12 | |||||
| 2014-03-31 | -$135.00K 10-Q · filed 2014-05-13 | |||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | -$18.00K 10-K · filed 2016-03-03 | -$135.00K 10-K · filed 2014-03-17 | |||
| 2013-09-30 | -$18.00K 10-Q · filed 2014-11-12 | -$135.00K 10-Q · filed 2013-11-13 | ||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-12 | |||||
| 2011-12-31 | -$117.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |